Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 10 04:00PM ET
1.92
Dollar change
-0.02
Percentage change
-1.03
%
Index- P/E- EPS (ttm)-43.79 Insider Own30.96% Shs Outstand1.48M Perf Week-4.00%
Market Cap5.25M Forward P/E- EPS next Y- Insider Trans-94.06% Shs Float1.04M Perf Month-48.11%
Income-9.26M PEG- EPS next Q- Inst Own2.30% Short Float15.10% Perf Quarter-73.33%
Sales0.00M P/S- EPS this Y- Inst Trans-73.34% Short Ratio0.13 Perf Half Y-86.38%
Book/sh-3.53 P/B- EPS next Y- ROA-108.70% Short Interest0.16M Perf Year-99.73%
Cash/sh1.24 P/C1.55 EPS next 5Y- ROE-4090.08% 52W Range1.76 - 1238.00 Perf YTD-68.00%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-99.84% Beta0.40
Dividend TTM- Quick Ratio0.39 Sales past 5Y0.00% Gross Margin- 52W Low9.09% ATR (14)0.78
Dividend Ex-Date- Current Ratio0.39 EPS Y/Y TTM-17.53% Oper. Margin- RSI (14)33.66 Volatility11.63% 17.59%
Employees9 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-61.35% Payout- Rel Volume0.11 Prev Close1.94
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume1.20M Price1.92
SMA20-13.67% SMA50-69.42% SMA200-93.58% Trades Volume136,011 Change-1.03%
Feb-06-25 08:15AM
Feb-05-25 08:00PM
Jan-07-25 08:13AM
Jan-06-25 08:00AM
Dec-06-24 09:00AM
08:45AM Loading…
Nov-15-24 08:45AM
Nov-11-24 08:15AM
Oct-21-24 09:00AM
Oct-02-24 09:15AM
Sep-25-24 09:17AM
Jul-08-24 08:00AM
Jun-13-24 08:15AM
Jun-06-24 10:15AM
08:00AM
May-15-24 08:00AM
09:00AM Loading…
Apr-30-24 09:00AM
Mar-07-24 07:00AM
Feb-14-24 04:48PM
Jun-05-23 08:00AM
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YK Bioventures Opportunities G10% OwnerDec 13 '24Sale0.062,998,908179,93413,005,169Dec 13 06:41 PM
YK Bioventures Opportunities G10% OwnerDec 12 '24Sale0.071,614,541113,01816,004,077Dec 13 06:41 PM
YK Bioventures Opportunities G10% OwnerDec 11 '24Sale0.081,343,801107,50417,618,618Dec 13 06:41 PM
YK Bioventures Opportunities G10% OwnerDec 06 '24Sale0.121,236,874148,42521,383,909Dec 10 08:44 PM
YK Bioventures Opportunities G10% OwnerDec 10 '24Sale0.091,570,947141,38518,962,419Dec 10 08:44 PM
YK Bioventures Opportunities G10% OwnerDec 09 '24Sale0.11850,54393,56020,533,366Dec 10 08:44 PM
SLOAN STUART M10% OwnerSep 25 '24Sale0.10532,48655,53821,067,956Nov 20 04:04 PM
YK Bioventures Opportunities G10% OwnerOct 10 '24Sale0.103,250,000325,00022,620,783Nov 14 08:14 PM